🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Das Produkt enthält den Wirkstoff Bimatoprost (Messwert: bis zu 0,055 %), der unter Aufsicht eines Augenarztes verwendet werden sollte. Die Verwendung des Produkts könnte zu Augen- und ophthalmischen Nebenwirkungen führen und sollte von schwangeren und stillenden Frauen nicht verwendet werden, da es das Kind beeinträchtigen könnte. Das Produkt entspricht nicht der Verordnung über kosmetische Mittel.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Stop of sales
Date of entry into force
28/08/2025
Type of economic operator taking notified measure
Other
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Eyelash Serum Gold
Risk Description (original English): The product contains the active substance bimatoprost (measured value up to 0.055%), which should be used under supervision of an ophthalmologist. Use of the product could result in ocular and ophthalmic side effects, and it should not be used by pregnant and breastfeeding women, as it may affect the child.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.